Adeno-associated virus (AAV) vectors represent a class of small, non-enveloped, replication-defective DNA viruses that are being developed for human gene therapy. AAV is the only non-pathogenic ...

Somatic gene transfer with vectors such as adeno-associated virus (AAV) can overcome these limitations. ReGenX's AAV Vector Technology gives extremely efficient and stable gene expression in ...

Key Takeaways from the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline Report DelveInsight’s Adeno-Associated Virus Vectors in Gene Therapy pipeline report depicts a robust space ...

Adeno-associated virus (AAV) is rapidly becoming the go-to biological delivery method for the latest gene therapy breakthroughs. AAV has an efficacy and safety profile that makes it an ideal ...